kinetic study on the reactions of platinum drugs with glutathione

kinetic study on the reactions of platinum drugs with glutathione A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer Platinum drug mechanism of action.

Name: kinetic study on the reactions of platinum drugs with glutathione A cisplatin-based platinum(IV) prodrug containing a s-transferase inhibitor to reverse cisplatin-resistance in non-small cell lung cancer Platinum drug mechanism of action.
Brand: metron-ms.com
SKU: 55826395669
Price: 28.01 USD
Availability: InStock
Rating: 4.6093 (27 reviews)

Platinum drug mechanism of action. Left: The established and well known Download Scientific Diagram kinetic study on the reactions of platinum drugs with glutathione Schematic representation A: Mode of action of platinum based drug Recent Advances of PlatinumBased Anticancer Catalytic Glutathione Oxidation and Platinum(IV) Prodrug Activation via a Ruthenium Flavin Catalyst Organometallics kinetic study on the reactions of platinum drugs with glutathione Glutathione Mediated Conjugation of Anticancer Drugs: The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs Chemical Reviews

SKU: 55826395669 · From metron-ms.com

4.6

USD28.01 USD61.01

Pay in 4 interest-free payments of $7.00 Learn more

Shipping Estimate
USA

USA

CAN

Ships within 48 hours · Estimated delivery Aug 2 - Aug 7

Description

It contains sodium hyaluronate, which provides deep hydration and keeps the skin plump and smooth all day long

Therefore, matrices were still needed to guarantee a sensitive detection of Pt-DDTC compounds

These intermediates can accumulate in the bladder, resulting in DNA damage and increased risk of bladder cancer (Lash and Parker, 2001)

This technique primarily involves the dispersion of small-molecule active compounds, sensitive materials, or volatile substances through physical or chemical methods, followed by the formation of microcapsules encapsulated with protective films (109)

The goal to be achieved in managing RA are to explain the underline mechanism behind the generation of antibodies to cartilaginous collagen as well as other oxidative stress condition generated in the synovial fluid, which may be used as marker in the early diagnosis of the disease